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Objectives: Open repair (OR) of inﬂammatory
abdominal aortic aneurysms (IAAA) is challenging due to
adhesions of the aneurysm with the surrounding structures
and can be associated with signiﬁcant morbidity. In recent
years endovascular aneurysm repair (EVAR) has emerged
as a promising, less invasive approach, although there is
a paucity of studies comparing directly these two methods
of repair. The aim of our retrospective comparative investi-
gation was to study IAAA outcome after OR compared to
EVAR.
Methods: Twenty seven patients (26 males, median
age 67 years) with a nonruptured IAAA were included.
Mean (sd) IAAA size was 6.0 (1.3) cm. Preoperative
pain was reported in 15 cases (56%). Nine patients
were managed with EVAR under local (n ¼ 8) or spinal
anaesthesia (n ¼ 1) and 18 with OR under general
anaesthesia.
Results: Preoperative characteristics of the two
study groups were comparable. In the EVAR group,
transfusion needs were reduced by 67%, procedure dura-
tion was shortened by 58% and postoperative hospitali-
zation was shortened by 4 days (50%), all statistically
signiﬁcant compared to OR (Table). A trend for
reduced morbidity and in-hospital mortality after EVAR
was also observed. No AAA-related death occurred
during follow-up.
Conclusions: Endovascular repair of IAAAs, accom-
plished in a less invasive manner, is associated with
a smoother postoperative course and shorter hospital stay
compared to OR. Further studies should focus on the
role of EVAR and provide long-term results, including
total and aneurysm-related mortality.Table. Results of endovascular and open repair of
inﬂammatory abdominal aortic aneurysms
Endovascular Open repair
repair (n ¼ 9) (n ¼ 16) P valueNumber of transfused
RBC units [median
(interquartile range)]1.0 (0-1) 3.0 (2.0-5.0) .001Procedure duration [median
(interquartile range)] (minutes)70 (68-105) 240 (180-360) .001Postoperative hospitalization
[median (interquartile
range)] (days)4.0 (2.5-7) 8.0 (6.5-11.5) .004Morbidity 11% 33% .36aIn-hospital mortality 0% 11% .54
Overall 5-year survival 100% 75% .75aOdds ratio 4.0.
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Objectives: We investigate the inﬂuence of severe
proximal neck angulation on mid-term outcome using
the Endurant Stentgraft.
Methods: A joint database of 3 tertiary institutions
was inquired. Inclusion in the study group was: suprarenal
neck angle (a) >60 or infrarenal neck angle (b) >75 (if
neck length #10 mm, a > 45 or b > 60). These were
compared to a matched control group without signiﬁcant
angulation, treated in the same period with the same
device. Primary endpoint was clinical success. 3D recon-
struction was used for measurements. Neck changes over
follow-up (FU) were evaluated. Estimates for clinical
success were obtained from Kaplan-Meier plots.
Results: From 2008 to 2009, 232 patients were
treated, and 45 were included in the study group (age 74
6 8, 86% men). Mean a was 51 6 21 and b was 81 6
16. Median FU was 3.0 yrs (2.0-3.4). Compared to the
control group (N ¼ 65), no differences were found in clin-
ical success (P ¼ .79, Fig). Two post-EVAR ruptures
occurred, one in each group. No differences were found in
rate or type of reinterventions. Over FU, neck dilatation
>2 mm occurred in 45% vs 43% in controls (P ¼ .23),
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study group were a -16 6 18 and b -29 6 23.
Conclusions: Severe proximal neck angulation had no
inﬂuence on mid-term results when using the Endurant
endograft. Device conformability resulted in minor
changes in neck angulation over time, possibly reducing
the risk of complications.
Fig.
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30-day mortality 30-day major morbidit
Odds ratio (P value) Odds ratio (P value)
Prior Stroke NS 2.42 (.019)
ASA Class 4 NS 3.49 (<.001)
Maximal aortic diameter, cm NS NS
Repair type descending-only
hybrid arch hybrid
thoracoabdominal
NS 7.33 (<.001)
4.36 (.021)
NS 2.40 (.006)
3.83 (<.001)
Nonelective status 2.87 (.045) NS
Increasing age 1.05 (.021) NS
Increasing BMI NS NS
ASA, American Society of Anesthesiologists; BMI, body mass index; LOS, lengtPS24.
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Surgery, Durham, NC
Objectives: Frailty has been examined in various popu-
lations as a predictor of morbidity/mortality, but not in
patients undergoing thoracic endovascular aortic repair
(TEVAR). The objective of this study was to evaluate the
role of frailty, as represented by total psoas volume (TPV),
in predicting morbidity & mortality following TEVAR.
Methods: Retrospective analysis was performed on all
patients undergoing TEVAR between 6/2005 and 10/
2012 at a single referral institution. Risk models for 30-day
and 1-year mortality, 30-day major morbidity, and discharge
to a facility were calculated using logistic regression
modeling. Major morbidity was deﬁned as reoperation, pro-
longed mechanical ventilation, acute renal failure, new onset
dialysis, stroke, discharge to a facility, and/or LOS>14 days.
Results: 383 patients were identiﬁed, with 338 (88%)
having data points for all variables used in the ﬁnal model.
Mortality for the cohort at 30 days and 1 year was 7% (n ¼
23) and 19% (n ¼ 62), respectively, while incidence of
major morbidity was 33% (n ¼ 108). TPV was not a statis-
tical signiﬁcant predictor of 30-day or 1-year outcomes.
History of stroke and ASA class 4 were signiﬁcant predic-
tors of all outcomes except 30 day mortality, with which
age, procedure type and nonelective status were statistically
associated (Table).
Conclusions: Frailty, as determined by TPV, does not
predict outcomes in TEVAR. An endovascular approach
may reduce the effect of frailty on morbidity and mortality
following TEVAR.
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Odds ratio (P value) Odds ratio (P value) Odds ratio (P value)
2.35 (.045) 3.42 (.006) 3.07 (.005)
3.04 (.002) 3.58 (.001) 2.17 (.013)
NS NS 1.26 (.016)
NS 7.44 (<.001)
5.05 (<.001)
NS NS NS NS 2.12 (.030) NS
2.88 (.013) NS NS
1.06 (<.001) NS 1.03 (.005)
NS NS 0.93 (.025)
h of stay; NS, nonsigniﬁcant.
